Epoetins and mortality in patients with cancer

Lancet. 2009 Jul 25;374(9686):287; author reply 287-8. doi: 10.1016/S0140-6736(09)61355-6.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Erythropoietin / adverse effects*
  • Guideline Adherence
  • Humans
  • Meta-Analysis as Topic*
  • Neoplasms / mortality*
  • Patient Selection
  • Practice Guidelines as Topic*
  • Recombinant Proteins
  • Research Design*
  • Survival Rate

Substances

  • Recombinant Proteins
  • Erythropoietin